Introduction to cGMP.

current Good Manufacturing Practice (GMP) in the pharmaceutical and medical device industry is a Food and Drug Agency (FDA) mandated requirement to ensure all production activities are executed by trained operatives following pre-approved documented procedures that utilize only fully validated and calibrated equipment, facilities and utilities. (21 CFR Part 820/210/211/11 Refers.)

FDA regulations use the phrase "current good manufacturing practice cgmp's" (GLP/GMP Validation) to describe these guidelines. Courts may theoretically hold that a drug product is adulterated even if there is no specific regulatory requirement that was violated as long as the process was not performed according to industry standards. By June 2010, the same GLP/GMP Validation requirements will apply to all manufacturers of dietary supplements. The World Health Organization (WHO) version of cGMP Validation is used by pharmaceutical regulators and the pharmaceutical industry in over one hundred countries worldwide, primarily in the developing world. The European Union's cGMP (EU-GMP) enforces similar requirements to WHO cGMP Validation, as does the Food and Drug Administration's version in the US. Similar cGMP Validations are used in other countries, with Australia, Canada, Japan, Singapore and others having highly developed/sophisticated current Good Manufacturing Practice requirements. In the United Kingdom, the Medicines Act (1968) covers most aspects of cGMP in what is commonly referred to as "The Orange Guide", which is named so because of the colour of its cover; it is officially known as Rules and Guidance for Pharma Manufacturers and Distributors.

Current Pharma Manufacturing Practices (for medicinal products) is that part of Quality Assurance which ensures that Medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization or product specification. cGMP is concerned with both production and quality control.

Graphic presentation depicting site Current Good Manufacturing Practice cGMP information.

cGMP Enforcement.

Current Good Manufacturing Practice (cGMP), are issued by regulatory authorities throughout the world, country by country and region by region. In general they list minimum standards for the safe manufacture, storage and distribution of medicinal drugs, devices and all associated records. GMP rules and FDA regulations are just as enforceable (in the country of their origin) as is common criminal law. Because pharmaceutical products and their raw materials are manufactured and distributed internationally, collaborations between manufacturing companies has led to national authorities introducing commonality in many specifications and standards; this is a continuous and ongoing process.

There are several different sections to GLP/GMP Validation requirements as detailed in CFR’s so it is essential to study those applicable to your processes. I.E. Medical Device, Biotech, Human Food, or Drugs. Manufacturers must adapt a very positive and proactive approach in conforming and enforcing the rules and guidelines throughout their entire manufacturing, inspecting, storing and distribution processes. They are required to implement processes and procedures that comply with the requirements listed in the applicable current Good Manufacturing Practices (cGMP) and gain approval from their regulatory authority that they comply with all of these regulations prior to being allowed to release their produce for public or prescribed use. They are subject to continuous monitoring of this regulated state.

Current Good Manufacturing Practice cGMP.

This image portrays current good manufacturing practices in action.

Current Good Manufacturing Practice cGMP and FDA regulations have been developed to ensure that medicinal pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use. They have been developed and introduced in 1962 in response to the US public’s concern about the safety, efficacy and overall quality of drugs. In the United States the regulations are called cGMP to take into account that the regulations are not static but rather dynamic. They are defined in Title 21 of the U.S. Code of Federal Regulations: 21 CFR 210 – current good Manufacturing Practice for drugs in general and 21 CFR 211 – Current good Manufacturing Practice, for finished pharmaceuticals. In 1996 the FDA proposed a significant revision of the regulation. Any drug marketed in the US must first receive FDA approval, and must be manufactured in accordance with the US cGMP regulations. Because of this, FDA regulations have set an international regulation benchmark for pharmaceutical manufacturing.

In Europe local current Good Manufacturing Practices cGMP, regulations exist in many countries. They are based on the European Union (EU) directive: Manufacturing Practice for Medicinal Products in the European Community. This EU GMP is necessary to permit free trade in medicinal products between the member countries. Regulations in the EU allow for the marketing of a new drug in the twelve member countries with a single marketing approval.

The EU GMP is intended to establish a minimum manufacturing standard for all member states.  The EU directive has been widely harmonized with the Guide to current excellent Manufacturing Practice for Pharmaceutical Products as developed by the Pharmaceutical Inspection Convention (PIC).10


For Your Security We are Now TLS 1.2 Compliant

PayPal Acceptance Mark


When assistance is required; please contact us TOLLFREE at 877-462-4048...If out of office hours; please leave a voice message.

Recent Articles

  1. Standard Operating Procedures | Templates | Validation Online

    May 21, 18 08:51 AM

    Standard Operating Procedures (SOP's) documents are mandated throughout all cGMP controlled industries. Tasks that are executed in the manufacture of cGMP regulated product must be clearly and concise…

    Read More

  2. Validation Master Plan | FDA | EU | WHO | Pharma | Med-device | Bio-t

    May 21, 18 06:43 AM

    VMP is an acronym for "Validation Master Plan", which must verify; by way of documented evidence, that all relevant requirements detailed in 21 CFR Part 210/820 have been integrated into all cGMP rela…

    Read More

  3. GAMP 5 Categories Software | FDA | EU | WHO | QbD | cGMP | FLCV | LC |

    May 21, 18 06:27 AM

    GAMP 5 is an acronym for "Good Automatic Manufacturing Practices Issue 5". Compiled by a committee & for GAMP requirements in general; it strives to answer all problems for all people. Learn; from our…

    Read More

  4. Computer Qualification | FDA | EU | WHO | Pharma | Med Dev | Bio-Tech

    May 20, 18 01:03 PM

    Study and learn by following the integral SOP that forms part of each of our documents. Following these SOP's will take you through the process of changing these templates into your own company bespok…

    Read More

  5. Pharmaceutical Validation | FDA | EU | WHO | Pharma | Med-Device | Bio

    May 20, 18 11:44 AM

    Learn the idiosyncrasies of Pharmaceutical Validation by using Validation Online’s uniquely intuitive cGMP compliant templates. An integrated SOP in each document will guide you through the process of…

    Read More

  6. Operation Validation. | FDA | EU | WHO | Pharma | Med-Device | Bio

    May 19, 18 12:45 PM

    Tutoring staff in validation skills is made easier when interactive fully detailed templated protocols are used. The possibility of discovering seriously embarrassing omissions when halfway through th…

    Read More

  7. Software Validation | FDA | EU | WHO | cGMP | QbD | FLCV | PLC

    May 19, 18 09:09 AM

    Learn how software validation can be greatly expedited when third generation 4Q protocols and plans are used. Start with the Validation, Requirements, Risk & Plan (VrrP) and finish with the combined D…

    Read More

  8. Software Qualification | FDA | EU | WHO | cGMP | QbD | FLCV | SOP's |

    May 15, 18 11:11 AM

    Learn how the use of a Software Qualification document package can ensure that your validation task is properly structured, adequately risk assessed and not over scoped. GMP compliant docs start with…

    Read More

  9. IQ OQ PQ | FDA | EU | WHO | GMP | QbD | Pharma | Med Div | Bio Tech |

    May 14, 18 08:41 AM

    Learn how the use of our Quality by Design (QbD) interactive IQ OQ PQ combination protocol templates can assure your validation task is correctly risk assessed, scoped appropriately & traceabilities b…

    Read More